2023 Was a tricky calendar year for your biopharma field, with numerous corporations downsizing and restructuring their workforces to remain afloat. You'll find signs of recovery, as mergers and acquisitions picked up throughout the pharmaceutical and daily life sciences field in the latter A part of 2023 and have continued https://sites.google.com/view/bio-sites/blog